Adjuvant chemotherapy for HER2-positive early breast cancer patients without perioperative radiotherapy in trastuzumab era.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e12573-e12573
Author(s):  
Kazuki Nozawa ◽  
Keiji Sugiyama ◽  
Kazuhiro Shiraishi ◽  
Yoriko Funahashi ◽  
Yoshihito Kogure ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Positive

Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients

2015 ◽  
Vol 11 (10) ◽  
pp. 1493-1500 ◽  
Author(s):  
G Mustacchi ◽  
F Puglisi ◽  
AM Molino ◽  
D Crivellari ◽  
C Ghiotto ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Observational Study ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Adjuvant Trastuzumab

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients

2015 ◽  
Vol 20 (4) ◽  
pp. 709-722 ◽  
Author(s):  
Hiroyasu Yamshiro ◽  
Hiroji Iwata ◽  
Norikazu Masuda ◽  
Naohito Yamamoto ◽  
Reiki Nishimura ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Trastuzumab Therapy

P104 Menstrual disorders during anthracycline-based adjuvant chemotherapy in very young early breast cancer patients

The Breast ◽  
2007 ◽  
Vol 16 ◽  
pp. S42
Author(s):  
Z. Neskovic-Konstantinovic ◽  
D. Strbac ◽  
S. Susnjar ◽  
D. Vukotic ◽  
D. Gavrilovic
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Menstrual Disorders
Sign in / Sign up

Export Citation Format

Share Document